UBE2D4 Antibody

What is UBE2D4 and why is it important in ubiquitination research?

UBE2D4 (ubiquitin-conjugating enzyme E2D4) is a member of the UBE2D subfamily of E2 ubiquitin-conjugating enzymes. It plays a critical role in the ubiquitin-proteasome system (UPS) by accepting ubiquitin from E1 enzymes and catalyzing its covalent attachment to target proteins . UBE2D4 is crucial for protein quality control and maintaining proteostasis, particularly during aging . Research has demonstrated that the UBE2D family contributes to various cellular processes, including protein degradation, cell cycle regulation, and stress responses. When designing experiments targeting UBE2D4, it's important to consider its high sequence homology with other UBE2D family members (UBE2D1, UBE2D2, and UBE2D3), which can complicate specific detection.

How do I select the appropriate UBE2D4 antibody for my research application?

Selecting the right UBE2D4 antibody requires careful consideration of several factors:

• Specificity vs. cross-reactivity: Determine whether you need an antibody specific to UBE2D4 or one that recognizes multiple UBE2D family members. Due to the high sequence similarity among UBE2D1/2/3/4 (approximately 90% identity), many commercial antibodies cross-react with multiple family members .

• Application compatibility: Verify the antibody has been validated for your specific application:

  Application	Common Dilutions	Considerations
  Western Blot	1:1000-1:12000	Expected MW: ~17 kDa
  IHC	1:20-1:3000	May require specific antigen retrieval
  IP	0.5-4.0 μg per sample	Verify binding efficiency

• Species reactivity: Most UBE2D4 antibodies react with human, mouse, and rat samples .

• Epitope location: Some antibodies target the C-terminal region (AA 111-140), while others target the full-length protein (AA 1-147) .

• Validation data: Review images of Western blots and IHC staining to ensure the antibody produces clean, specific signals with minimal background .

How can I achieve optimal detection of UBE2D4 in Western blotting experiments?

For optimal Western blot detection of UBE2D4:

• Sample preparation: Use RIPA buffer supplemented with protease inhibitors and N-ethylmaleimide (10 mM) to prevent deubiquitination during lysis.

• Protein loading: Load 20-30 μg of total protein for cell lines (HEK-293, HeLa, Jurkat) and 40-50 μg for tissue samples (brain, heart, kidney) .

• Gel selection: Use 12-15% SDS-PAGE gels to achieve good separation around the 17 kDa range.

• Transfer conditions: For optimal transfer of low molecular weight proteins like UBE2D4:

  • Use PVDF membranes with 0.2 μm pore size

  • Transfer at 100V for 60 minutes in cold transfer buffer containing 20% methanol

  • Alternatively, use a semi-dry transfer system at 25V for 30 minutes

• Blocking and antibody incubation:

  • Block with 5% non-fat milk in TBST for 1 hour at room temperature

  • Incubate with primary antibody (1:2000-1:4000 dilution) overnight at 4°C

  • Wash thoroughly (3-5 times, 5 minutes each) with TBST

  • Incubate with appropriate secondary antibody for 1 hour at room temperature

• Detection: Use enhanced chemiluminescence with exposure times of 30 seconds to 2 minutes to visualize the 17 kDa band corresponding to UBE2D4 .

What controls should I include when performing UBE2D4 knockdown or knockout experiments?

When conducting UBE2D4 knockdown or knockout experiments, include the following controls:

• Positive and negative expression controls:

  • Positive control: Samples known to express UBE2D4 (HEK-293, HeLa, Jurkat cells)

  • Negative control: Samples with UBE2D4 knockdown or knockout

• Specificity controls:

  • Non-targeting siRNA/shRNA for RNAi experiments

  • Scrambled guide RNA for CRISPR-Cas9 experiments

  • Empty vector for overexpression studies

• Functional controls:

  • Rescue experiments: Express human UBE2D4 in UBE2D4-knockdown cells to confirm phenotype specificity

  • Monitor levels of other UBE2D family members to assess potential compensatory mechanisms

• Validation of knockdown/knockout:

  • Verify UBE2D4 reduction by Western blot (protein level)

  • Confirm reduction of mRNA levels by qRT-PCR

  • Assess the accumulation of ubiquitinated proteins as a functional readout

Research by Smith et al. demonstrated that knockdown of UBE2D family members can have distinct phenotypic effects, with UBE2D1 and UBE2D2 knockdown causing significant increases in VEGFR2 levels, while UBE2D3 and UBE2D4 knockdown had minimal effects . This highlights the importance of including controls for all family members when studying specific UBE2D proteins.

Why might I observe multiple bands when performing Western blot for UBE2D4?

Multiple bands on UBE2D4 Western blots can result from several factors:

• Cross-reactivity with other UBE2D family members: Due to the high sequence similarity (~90% identity) between UBE2D1, UBE2D2, UBE2D3, and UBE2D4, antibodies may detect multiple family members, even when marketed as specific . Research by Smith et al. observed that some antibodies could not distinguish between UBE2D isoforms, particularly UBE2D1 and UBE2D2 .

• Post-translational modifications: UBE2D4 can itself be ubiquitinated or modified by other PTMs, generating higher molecular weight bands:

  • Mono-ubiquitination: additional band at ~25 kDa

  • Poly-ubiquitination: smear at higher molecular weights

  • SUMOylation: additional bands at ~30-40 kDa

• Protein degradation: Partial degradation can produce fragments of lower molecular weights.

• Splice variants: UBE2D4 may have alternative splice variants that produce proteins of different sizes.

To resolve this issue:

• Use antibodies targeting specific epitopes unique to UBE2D4

• Include UBE2D4 knockdown/knockout controls to identify specific bands

• Use recombinant UBE2D4 protein as a positive control to confirm the expected molecular weight

• If studying ubiquitinated forms, consider including deubiquitinating enzyme inhibitors like N-ethylmaleimide (10 mM) in your lysis buffer

How can I distinguish between different UBE2D family members in my experiments?

Distinguishing between highly homologous UBE2D family members requires careful experimental design:

• Antibody selection:

  • Use antibodies targeting unique regions of UBE2D4

  • Validate antibody specificity using overexpression or knockdown of individual UBE2D family members

• Genetic approaches:

  • Employ isoform-specific siRNA knockdown targeting the 3'UTR or other divergent regions

  • Verify knockdown specificity using qRT-PCR with isoform-specific primers

  • Conduct rescue experiments with human UBE2D4 in knockdown models

• Functional assays:
  Research has shown that different UBE2D family members have distinct functions despite their sequence similarity. For example:

  • UBE2D1 and UBE2D2 knockdown causes significant increases in VEGFR2 levels (2-3 fold), while UBE2D3 and UBE2D4 knockdown has minimal effects

  • Human UBE2D2 rescues phenotypes caused by eff (Drosophila homolog of UBE2D) knockdown more effectively than UBE2D4

• Mass spectrometry:

  • Use targeted proteomics to identify unique peptides from each UBE2D family member

  • Employ stable isotope labeled internal standards for absolute quantification

• Comparative expression analysis:
  Create a table of tissue-specific expression patterns to help identify which UBE2D family members are likely to be present in your experimental system:

  Tissue/Cell Type	UBE2D1	UBE2D2	UBE2D3	UBE2D4
  Endothelial cells	High	High	Moderate	Low
  Skeletal muscle	Moderate	High	Moderate	Low
  Brain	High	Moderate	High	Low
  Kidney	High	Moderate	Moderate	Low

How can UBE2D4 antibodies be used to study aging-related proteostasis mechanisms?

Recent research has demonstrated that UBE2D family proteins play crucial roles in maintaining proteostasis during aging . To study the role of UBE2D4 in aging-related proteostasis:

• Temporal expression analysis:

  • Use UBE2D4 antibodies to quantify protein levels across different age groups in various tissues

  • Compare UBE2D4 expression with other UBE2D family members to identify age-specific changes

  Research has shown that UBE2D/eff protein levels decline with aging, and this decline correlates with increased accumulation of protein aggregates .

• Co-immunoprecipitation studies:

  • Use UBE2D4 antibodies for IP followed by mass spectrometry to identify age-dependent interactors

  • Verify interactions with known components of the ubiquitin-proteasome system

• Aggregate analysis:

  • Employ UBE2D4 antibodies in immunofluorescence microscopy to study colocalization with age-related protein aggregates

  • Quantify ubiquitinated protein levels in soluble and insoluble fractions in UBE2D4 knockdown models

• Rescue experiments:

  • Overexpress UBE2D4 in aged tissues/cells and assess improvements in proteostasis

  • Compare the efficacy of UBE2D4 versus other UBE2D family members in rescuing age-related phenotypes

• Proteome-wide analysis:
  Recent studies using TMT-based proteomics identified key proteins modulated by UBE2D/eff knockdown, including Arc1, Arc2, Gnmt, and CG4594 . These proteins accumulated upon UBE2D knockdown and were reduced by human UBE2D2 expression, providing potential biomarkers for UBE2D4 activity in aging.

What are the considerations for using UBE2D4 antibodies in targeted protein degradation (TPD) research?

When using UBE2D4 antibodies in targeted protein degradation research:

• Target engagement verification:

  • Use UBE2D4 antibodies to confirm target engagement of UBE2D4-recruiting degraders

  • Quantify the percentage of UBE2D4 engaged by degraders (e.g., using cellular thermal shift assays or competitive binding assays)

• Mechanism characterization:

  • Employ UBE2D4 antibodies to track the formation of ternary complexes with E3 ligases and substrate proteins

  • Use IP with UBE2D4 antibodies followed by Western blotting to verify the association with target proteins in the presence of degraders

• Binding site analysis:

  • Use UBE2D4 antibodies in competition assays to map the binding sites of novel UBE2D4 recruiters

  • Research by Roumeliotis et al. identified a covalent recruiter (EN67) targeting an allosteric cysteine (C111) of UBE2D without affecting enzymatic activity

• Resistance mechanism studies:

  • Examine UBE2D4 expression levels in cells resistant to targeted protein degradation

  • Research has shown that resistance to degraders can involve impairment of the engaged ubiquitin transfer pathway

• Isoform specificity analysis:

  • Compare degrader activity in cells expressing different UBE2D family members

  • Research indicates that EN67 likely targets all four isoforms of UBE2D due to high sequence identity, particularly around the C111 residue

How does UBE2D4 function differ from other UBE2D family members in cellular contexts?

Despite high sequence similarity, UBE2D family members exhibit functional differences in various cellular contexts:

• VEGFR2 regulation:
  Research by Smith et al. revealed distinct effects of UBE2D family members on VEGFR2 regulation in endothelial cells:

  • UBE2D1 knockdown: ~2-fold increase in VEGFR2 levels

  • UBE2D2 knockdown: ~1.6-fold increase in VEGFR2 levels

  • UBE2D3 and UBE2D4 knockdown: minimal effect on VEGFR2 levels

  These findings suggest that UBE2D4 plays a lesser role in VEGFR2 regulation compared to UBE2D1 and UBE2D2.

• Proteostasis maintenance:
  Studies in Drosophila models showed that human UBE2D2 more effectively rescued phenotypes caused by eff (Drosophila homolog of UBE2D) knockdown compared to UBE2D4:

  • UBE2D2 strongly rescued depigmentation caused by eff knockdown

  • UBE2D4 showed lower rescue efficiency

  This indicates potential functional differences between UBE2D2 and UBE2D4 in proteostasis maintenance.

• Substrate specificity:
  Proteomics analyses identified proteins specifically modulated by UBE2D/eff, including:

  • Arc1 and Arc2 (activity-regulated cytoskeleton-associated proteins)

  • Gnmt (glycine N-methyltransferase)

  • CG4594 (fatty acid beta-oxidation enzyme)

  The relative contribution of UBE2D4 versus other family members in regulating these specific substrates requires further investigation.

• Comparative functional analysis table:

  Function	UBE2D1	UBE2D2	UBE2D3	UBE2D4
  VEGFR2 regulation	Strong effect	Moderate effect	Minimal effect	Minimal effect
  Rescue of eff knockdown	Not tested	Strong rescue	Not tested	Partial rescue
  Proteostasis maintenance	Important	Critical	Important	Contributory
  Targeted protein degradation	Targetable	Targetable	Targetable	Targetable

What methodological approaches can differentiate the functional contributions of UBE2D4 from other family members?

To differentiate the functional contributions of UBE2D4 from other UBE2D family members:

• Combinatorial knockdown/knockout strategies:

  • Individual knockdown of each UBE2D family member

  • Double knockdown combinations to identify functional redundancy

  • Sequential knockdown to detect compensatory mechanisms

  Research shows that UBE2D1 and UBE2D2 knockdown produces distinct phenotypes compared to UBE2D3 and UBE2D4 knockdown in VEGFR2 regulation .

• Specific substrate identification:

  • Immunoprecipitate UBE2D4 using specific antibodies and identify interacting proteins by mass spectrometry

  • Compare interactomes of different UBE2D family members to identify unique substrates

• Domain swap experiments:

  • Create chimeric proteins with domains exchanged between UBE2D family members

  • Assess their ability to rescue phenotypes in knockdown models

  Research demonstrates that human UBE2D2 and UBE2D4 have different rescue efficiencies in Drosophila eff knockdown models .

• Selective inhibition:

  • Develop isoform-specific inhibitors or degraders targeting unique regions of UBE2D4

  • Use degraders like EN67 that target conserved residues (e.g., C111) to deplete all UBE2D family members

• Quantitative proteomics:

  • Perform TMT-based proteomics on samples with selective knockdown of each UBE2D family member

  • Identify protein changes specific to UBE2D4 depletion versus other family members

  This approach revealed that UBE2D/eff knockdown affects levels of proteins like Arc1, Arc2, Gnmt, and CG4594 .

• Temporal expression analysis:

  • Study the expression patterns of UBE2D family members during aging or stress conditions

  • Identify conditions where UBE2D4 expression is differentially regulated compared to other family members